Results 21 to 30 of about 5,147 (131)

Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review [PDF]

open access: yesInternational Journal of Environmental Research and Public Health, 2021
Wioletta Anna Mędrzycka-Dąbrowska   +2 more
exaly   +2 more sources

Alone on a collagen island: Unique findings of osseous sclerotic bodies in nephrogenic systemic fibrosis [PDF]

open access: yesJAAD Case Reports, 2023
Emily R. Gordon, BA   +8 more
doaj   +2 more sources

An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. [PDF]

open access: yesPLoS ONE, 2015
Nephrogenic systemic fibrosis (NSF) is a rare but serious disorder disease affecting patients with advanced renal disease. Although multiple studies have indicated an association between gadolinium-based contrast agents (GBCAs) and NSF, some studies ...
Bin Zhang   +4 more
doaj   +2 more sources

Gadolinium and nephrogenic systemic fibrosis [PDF]

open access: yesKidney International, 2007
Nephrogenic systemic fibrosis (NSF) is characterized by red skin areas or plaques that over several weeks successively develop to painful thickened skin with a 'woody' texture, resembling 'peau d'orange'. Starting at the extremities, it may spread to the trunk, and may progressively inhibit flexion of adjacent joints. In skin biopsies of affected areas,
Grobner, T., Prischl, F.C.
openaire   +2 more sources

Complications of nephrogenic systemic fibrosis following repeated exposure to gadolinium in a man with hypothyroidism: a case report

open access: yesJournal of Medical Case Reports, 2011
Introduction Nephrogenic systemic fibrosis is a condition that has recently been recognized in patients with chronic renal disease and is associated with use of gadolinium-based contrast agents of ubiquitous use in magnetic resonance imaging scans.
Aggarwal Arpita   +5 more
doaj   +1 more source

Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media

open access: yesSouth African Journal of Radiology, 2013
Nephrogenic systemic fibrosis (NSF), unknown before March 1997 and first described in 2000, is a systemic disorder characterised by widespread tissue fibrosis.
P.S. Ngoya, Z Vawda, J.W Lotz
doaj   +1 more source

Nephrogenic Systemic Fibrosis Associated with Gadolinium Use

open access: yesJournal of the Formosan Medical Association, 2008
Nephrogenic systemic fibrosis (NSF) is an idiopathic, progressive, systemic fibrosis that occurs in patients with renal diseases. Recently, gadolinium-containing contrast (Gd-contrast) has become a suspected causal factor for NFS.
Chi-Chao Chao   +5 more
doaj   +1 more source

A moderate response to plasmapheresis in nephrogenic systemic fibrosis

open access: yesClinics and Practice, 2011
Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium ...
Pelin Ustuner   +3 more
doaj   +1 more source

Nephrogenic systemic fibrosis: concepts and perspectives Fibrose nefrogênica sistêmica: conceitos e perspectivas

open access: yesAnais Brasileiros de Dermatologia, 2012
Nephrogenic systemic fibrosis is a chronic, progressive condition that develops in some patients with renal impairment after exposure to gadolinium-based contrast agents used in magnetic resonance imaging.
Ana Carolina de Souza Machado Igreja   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy